tiprankstipranks
Eyenovia plans to terminate Phase 3 CHAPERONE study after DRC review
PremiumThe FlyEyenovia plans to terminate Phase 3 CHAPERONE study after DRC review
5d ago
Eyenovia price target lowered to $4.50 from $7 at Ladenburg
Premium
The Fly
Eyenovia price target lowered to $4.50 from $7 at Ladenburg
7d ago
Eyenovia’s Strategic Advances and Q3 Financials
Premium
Company Announcements
Eyenovia’s Strategic Advances and Q3 Financials
8d ago
Eyenovia files $100M mixed securities shelf
PremiumThe FlyEyenovia files $100M mixed securities shelf
2M ago
Eyenovia commences manufacturing of second generation Optejet device
Premium
The Fly
Eyenovia commences manufacturing of second generation Optejet device
2M ago
Eyenovia Announces Share Offering and Warrant Sale for Growth
Premium
Company Announcements
Eyenovia Announces Share Offering and Warrant Sale for Growth
2M ago
Eyenovia announces appointment of Andrew Jones as CFO
PremiumThe FlyEyenovia announces appointment of Andrew Jones as CFO
3M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
Eyenovia Unveils Updated Corporate Presentation for Stakeholders
Premium
Company Announcements
Eyenovia Unveils Updated Corporate Presentation for Stakeholders
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100